Sanara MedTech
SMTI
74 hedge funds and large institutions have $45.2M invested in Sanara MedTech in 2026 Q2 according to their latest regulatory filings, with 15 funds opening new positions, 33 increasing their positions, 14 reducing their positions, and 4 closing their positions.
380% more capital inflows, than outflows
Capital inflows: $11.2M | Capital outflows: $2.33M
275% more first-time investments, than exits
New positions opened: 15 | Existing positions closed: 4
136% more repeat investments, than reductions
Existing positions increased: 33 | Existing positions reduced: 14
14% more funds holding
Funds holding: 65 → 74 (+9)
4.62% more ownership
Funds ownership: 16.28% → 20.91% (+4.6%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
+$2.7M |
| 2 |
AQR Capital Management
Greenwich,
Connecticut
|
+$1.49M |
| 3 |
Goldman Sachs
New York
|
+$1.09M |
| 4 |
Vanguard Capital Management
Malvern,
Pennsylvania
|
+$900K |
| 5 |
Jacobs Levy Equity Management
Florham Park,
New Jersey
|
+$654K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Marshall Wace
London,
United Kingdom
|
-$555K |
| 2 |
Squarepoint
New York
|
-$409K |
| 3 |
BNP Paribas Financial Markets
Paris,
France
|
-$278K |
| 4 |
XTX Topco
George Town,
Cayman Islands
|
-$217K |
| 5 |
Salem Investment Counselors
Winston Salem,
North Carolina
|
-$187K |
SMTI Hedge Fund Activity: Q2 2026 in Review
74 of the 8,395 institutional investors tracked by Wall St. Rank reported a position in Sanara MedTech (SMTI) for Q2 2026, worth a combined $45.2M — up 76% from $25.6M a quarter earlier.
Buyers outnumbered sellers: 15 funds opened new SMTI positions and 4 closed out — a net gain of 11 holders — while 33 added to existing stakes and 14 trimmed.
The largest buyer was Royal Bank of Canada, adding an estimated $2.7M. The largest seller was Marshall Wace, cutting an estimated $555K.
- 74 institutional investors held Sanara MedTech (SMTI) as of Q2 2026, up from 65 in Q1 2026.
- Funds reported $45.2M of Sanara MedTech stock for Q2 2026, up 76% quarter-over-quarter.
- 15 funds opened new Sanara MedTech positions in Q2 2026 and 4 closed out, a net change of +11 holders.
- The largest Sanara MedTech buyer in Q2 2026 was Royal Bank of Canada, an estimated $2.7M added.
- The largest Sanara MedTech seller in Q2 2026 was Marshall Wace, an estimated $555K sold.
Based on aggregated 13F filings for Q2 2026.